April 11, 2022
Decade-Long 340B Tailwind Gives Way to Significant Pharmacy Headwind in 1Q 2022
April 11, 2022
Protected: China Diagnostics & Market Update KOL Call
April 7, 2022
March Musings: Community Oncology Event Highlights Busy Month of Research
March 30, 2022
Protected: KOL Views on Biopharma Services for CROs & Tools – REPLAY
March 3, 2022
Protected: Nephron Research Community Oncology Symposium – REPLAY
March 3, 2022
Protected: KOL Views on Lab & COVID Dx Testing w/ Dr. Robert Boorstein at Lenco Labs
February 10, 2022
Toward an Endemic Covid-19 State
February 9, 2022
A Moonshot for LBx: NCI RCT Would Separate MCED Winners & Losers
February 4, 2022
Protected: Nephron Research Private Equity Panel – February 3rd
January 31, 2022
Protected: Healthcare Bull/Bear Debates to Start 2022 – Jan. 28th, 2022
January 26, 2022
Protected: KOL Views on CRC Diagnostics for Cologuard & Liquid Biopsy Post ASCO-GI – Jan. 24th, 2022
January 21, 2022
Protected: KOL Views on Genomics Innovation w/ Dr. Chris Mason at Weill Cornell – Jan. 19th, 2022
January 12, 2022
BIIB’s Aduhelm: Medicare Coverage Proposal for Alzheimer’s Drugs
December 16, 2021
Protected: Nephron Research 2022 Outlook Call Replay
December 9, 2021
Nephron’s Simpson on Durable Medical Equipment Pay Rule; CGMs